Monday 8th July 2024 |
Text too small? |
Chatham Rock Phosphate Limited (CRP) has announced that it will be undertaking a share purchase plan offer of ordinary shares (New Shares) to its eligible shareholders resident in New Zealand (being those holders on the CRP share register resident in New Zealand on the record date of 5pm, 5 July 2024) (Offer).
Eligible shareholders may apply for a minimum of 5,000 New Shares and up to 100,000 New Shares at NZD$0.10 per share under the Offer. New Shares issued under the share purchase plan will rank equally with each other and will have the same voting rights, dividend rights and other entitlements as existing fully paid shares in CRP.
Pursuant to clause 20(1)(a) of Schedule 8 of the Financial Markets Conduct Regulations 2014 (Regulations) and clause 19 of Schedule 1 of the Financial Markets Conduct Act 2013 (FMCA), CRP advises that:
1 The Offer is being made to investors in reliance upon the exclusion in clause 19(1) of Schedule 1 of the FMCA. CRP is giving this notice (Cleansing Notice) under clause 20(1)(a) of Schedule 8 of the Regulations.
2 As at the date of this Cleansing Notice, CRP is in compliance with:
2.1 the continuous disclosure obligations that apply to it in relation to CRP’s quoted financial products; and
2.2 its financial reporting obligations (as defined in the Regulations).
3 As at the date of this Cleansing Notice, there is no information that is “excluded information” within the meaning set out in clause 20(5) of Schedule 8 of the Regulations.
4 The Offer is not expected to have any effect on the control of CRP within the meaning set out in clause 48 of Schedule 1 of the FMCA.
Please refer to the Offer Booklet for more information.
No comments yet
Chorus considers Capital Notes offer
May 5th Morning Report
KPG - Kiwi Property announces GM Corporate Services
Mainfreight Limited - Trading Conditions Update 2 May 2025
SIML - Change to Executive Team
BAI - Divestment of education group
May 2nd Morning Report
MMH - Marsden Maritime Holdings (MMH) releases Scheme Booklet
CVT - Comvita announces change to Board of Directors
TRU - Published Saudi Arabia Study Confirms TruScreen's Results